What is Datos?
Datos Health operates at the intersection of artificial intelligence and clinical care, providing a robust remote patient monitoring platform designed to automate complex care pathways. The company's OpenCare platform serves as a critical tool for healthcare providers, enabling the seamless integration of patient-generated data into clinical decision-making processes. By focusing on cardiac rehabilitation, oncology, and chronic disease management, Datos addresses the growing demand for scalable, automated solutions that reduce clinician burnout while simultaneously improving patient outcomes. Their technology facilitates a shift from traditional, reactive monitoring to a proactive, continuous care experience, effectively bridging the gap between hospital-based interventions and home-based recovery.
How much funding has Datos raised?
Datos has raised a total of $7M across 1 funding round:
Series A
$7M
Series A (2020): $7M with participation from Industry Ventures, Vertex, Crescendo Venture Partners, and Angular Ventures
Key Investors in Datos
Industry Ventures
A private equity and venture capital firm specializing in flexible capital solutions across the full lifecycle of venture investing, supporting companies from early-stage through growth.
Vertex
A global venture capital firm focused on investing in transformative companies within the healthcare and technology sectors.
Crescendo Venture Partners
A venture capital firm that partners with early-stage technology companies to provide strategic guidance and capital for long-term growth.
What's next for Datos?
With this major enterprise-level funding, Datos is poised to expand its footprint in the global healthcare technology market. The strategic allocation of these resources will likely focus on deepening the platform's AI capabilities, broadening the scope of customizable care pathways, and strengthening partnerships with large-scale health systems. As the industry continues to prioritize remote care as a standard of practice, Datos is well-positioned to capitalize on the transition toward value-based care models. Future growth will likely involve scaling operations to meet the increasing demand for interoperable, patient-centric digital health tools that can adapt to the evolving needs of both clinicians and patients in a post-pandemic landscape.
See full Datos company page
